Dan Liu

Bispecific CAR T cell therapy targeting BCMA and CD19 in relapsed/refractory multiple myeloma: a phase I/II trial

Ming Shi, Jiaojiao Wang, Hongming Huang et al. · Nature Communications · 2024 · 104 citations · Full text

Medicine, Immunology, Oncology +16

BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy

Wei Zhang, Dan Liu, Tao Zhang et al. · hLife · 2024 · 16 citations · Full text

Life Sciences, Neurology, Neuroscience +14

Plasma exosomes contain protein biomarkers valuable for the diagnosis of lung cancer

Zhiqiang Liu, Hong Huang, Jing Ren et al. · Discover Oncology · 2024 · 10 citations · Full text

Medicine, Molecular Biology, Oncology +17

Safety and efficacy of selpercatinib in pediatric patients with RET-altered solid tumors: Updated results from LIBRETTO-121.

Daniel A. Morgenstern, Michela Casanova, Cornelis M. van Tilburg et al. · Journal of Clinical Oncology · 2024 · 10 citations

Medicine, Oncology, Pharmacology +15

Anti-BCMA/CD19 CAR T cell therapy in patients with refractory generalized myasthenia gravis: a single-arm, phase 1 trial

Yong Zhang, Dan Liu, Zhouao Zhang et al. · EClinicalMedicine · 2025 · 10 citations · Full text

Life Sciences, Immunology, Cell Therapy +15